European Union Drugs Agency. (2025) EU drug market: heroin and other opioids — in-depth analysis (European drug report 2025). Lisbon: EUDA.
External website: https://www.euda.europa.eu/publications/european-d...
Heroin remains Europe’s most commonly used illicit opioid and is responsible for a large share of the health burden attributed to illicit drug consumption. Europe’s opioid problem, however, continues to evolve in ways that are likely to have important implications for how we address issues in this area. On this page, you can find the latest analysis of the drug situation for heroin and other opioids in Europe, including prevalence of use, treatment demand, seizures, price and purity, harms and more.
This page is part of the European Drug Report 2025, the EUDA’s annual overview of the drug situation in Europe.
B Substances > Opioids (opiates)
B Substances > Opioids (opiates) > Heroin (diacetylmorphine / diamorphine)
B Substances > New (novel) psychoactive substances > Synthetic opioids
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
MM-MO Crime and law > Crime > Substance related crime > Crime associated with substance production and distribution
MM-MO Crime and law > Substance related offence > Drug offence > Illegal production of drugs
MM-MO Crime and law > Substance related offence > Drug offence > Illegal distribution of drugs (drug market / dealing)
MM-MO Crime and law > Substance related offence > Drug offence > Illegal drug possession (seizures)
VA Geographic area > Europe
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page